Reubi, Jean-Claude

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2012 | 2011 | 2010 | 2007 | 2006

2012

Körner, Meike; Christ, Emanuel; Wild, Damian; Reubi, Jean Claude (2012). Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications. Frontiers in endocrinology, 3, p. 158. Lausanne: Frontiers Research Foundation 10.3389/fendo.2012.00158

2011

Wild, Damian; Christ, Emanuel; Caplin, Martyn E; Kurzawinski, Tom R; Forrer, Flavio; Brändle, Michael; Seufert, Jochen; Weber, Wolfgang A; Bomanji, Jamshed; Perren, Aurel; Ell, Peter J; Reubi, Jean Claude (2011). Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. Journal of nuclear medicine, 52(7), pp. 1073-8. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.110.085142

Fourmy, Daniel; Gigoux, Véronique; Reubi, Jean Claude (2011). Gastrin in gastrointestinal diseases. Gastroenterology, 141(3), 814-818.e1-3. Philadelphia, Pa.: Elsevier 10.1053/j.gastro.2011.07.006

2010

Reubi, Jean Claude; Erchegyi, Judit; Cescato, Renzo; Waser, Beatrice; Rivier, Jean E (2010). Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analog. European journal of nuclear medicine and molecular imaging, 37(8), pp. 1551-8. Berlin: Springer-Verlag 10.1007/s00259-010-1445-x

2007

de Visser, M; Bernard, H F; Erion, J L; Schmidt, M A; Srinivasan, A; Waser, B; Reubi, J C; Krenning, E P; de Jong, M (2007). Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours. European journal of nuclear medicine and molecular imaging, 34(8), pp. 1228-38. Berlin: Springer 10.1007/s00259-006-0356-3

Zhang, Hanwen; Schuhmacher, Jochen; Waser, Beatrice; Wild, Damian; Eisenhut, Michael; Reubi, Jean Claude; Maecke, Helmut R (2007). DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours. European journal of nuclear medicine and molecular imaging, 34(8), pp. 1198-208. Berlin: Springer 10.1007/s00259-006-0347-4

Antunes, Patricia; Ginj, Mihaela; Walter, Martin A; Chen, Jianhua; Reubi, Jean-Claude; Maecke, Helmut R (2007). Influence of different spacers on the biological profile of a DOTA-somatostatin analogue. Bioconjugate chemistry, 18(1), pp. 84-92. Washington, D.C.: American Chemical Society 10.1021/bc0601673

Antunes, P; Ginj, M; Zhang, H; Waser, B; Baum, R P; Reubi, J C; Maecke, H (2007). Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? European journal of nuclear medicine and molecular imaging, 34(7), pp. 982-93. Berlin: Springer 10.1007/s00259-006-0317-x

Körner, Meike; Reubi, Jean Claude (2007). NPY receptors in human cancer: a review of current knowledge. Peptides, 28(2), pp. 419-25. New York, N.Y.: Elsevier 10.1016/j.peptides.2006.08.037

Melis, M; Forrer, F; Capello, A; Bijster, M; Bernard, B F; Reubi, J C; Krenning, E P; De Jong, M (2007). Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [(177)Lu-DOTA(0),Tyr(3)]octreotate therapy. Quarterly journal of nuclear medicine and molecular imaging, 51(4), pp. 324-33. Torino: Minerva Medica

Reubi, Jean Claude (2007). Targeting CCK receptors in human cancers. Current topics in medicinal chemistry, 7(12), pp. 1239-42. Hilversum: Bentham Science Publishers

Fainstein Day, Patricia; Frohman, Lawrence; Garcia Rivello, Hernan; Reubi, Jean Claude; Sevlever, Gustavo; Glerean, Mariela; Fernandez Gianotti, Tomas; Pietrani, Marcelo; Rabadan, Alejandra; Racioppi, Silvina; Bidlingmaier, Martin (2007). Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment. Pituitary, 10(3), pp. 311-9. Norwell, Mass.: Springer Science + Business Media 10.1007/s11102-007-0019-9

Storch, D; Schmitt, JS; Waldherr, C; Waser, B; Reubi, JC; Maecke, HR (2007). Preclinical evaluation of somatostatin analogs bearing two macrocyclic chelators for high specific activity labeling with radiometals. Radiochimica acta, 95(6), pp. 359-69. München: Oldenbourg 10.1524/ract.2007.95.6.359

2006

Körner, Meike; Hayes, Gregory M; Rehmann, Ruth; Zimmermann, Arthur; Scholz, Arne; Wiedenmann, Bertram; Miller, Laurence J; Reubi, Jean Claude (2006). Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma. Journal of hepatology, 45(6), pp. 825-35. Amsterdam: Elsevier 10.1016/j.jhep.2006.06.016

Waser, Beatrice; Rehmann, Ruth; Rivier, Jean; Vale, Wylie; Reubi, Jean Claude (2006). CRF receptors in the rodent and human cardiovascular systems: Species differences. Peptides, 27(12), pp. 3029-38. New York, N.Y.: Elsevier 10.1016/j.peptides.2006.07.005

Cescato, Renzo; Schulz, Stefan; Waser, Beatrice; Eltschinger, Véronique; Rivier, Jean E; Wester, Hans-Jürgen; Culler, Michael; Ginj, Mihaela; Liu, Qisheng; Schonbrunn, Agnes; Reubi, Jean Claude (2006). Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. Journal of nuclear medicine, 47(3), pp. 502-11. New York, N.Y.: Society of Nuclear Medicine

Schmassmann, Adrian; Zoidl, Georg; Peskar, Brigitta M; Waser, Bea; Schmassmann-Suhijar, Diana; Gebbers, Jan-Olaf; Reubi, Jean Claude (2006). Role of the different isoforms of cyclooxygenase and nitric oxide synthase during gastric ulcer healing in cyclooxygenase-1 and -2 knockout mice. American journal of physiology - gastrointestinal and liver physiology, 290(4), G747-56. Bethesda, Md.: American Physiological Society 10.1152/ajpgi.00416.2005

Wild, Damian; Béhé, Martin; Wicki, Andreas; Storch, Daniel; Waser, Beatrice; Gotthardt, Martin; Keil, Boris; Christofori, Gerhard; Reubi, Jean Claude; Mäcke, Helmut R (2006). [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting. Journal of nuclear medicine, 47(12), pp. 2025-33. New York, N.Y.: Society of Nuclear Medicine

Ginj, Mihaela; Zhang, Hanwen; Waser, Beatrice; Cescato, Renzo; Wild, Damian; Wang, Xuejuan; Erchegyi, Judit; Rivier, Jean; Mäcke, Helmut R; Reubi, Jean Claude (2006). Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 103(44), pp. 16436-41. Washington, D.C.: National Academy of Sciences NAS 10.1073/pnas.0607761103

Ginj, Mihaela; Schmitt, Jörg S; Chen, Jianhua; Waser, Beatrice; Reubi, Jean-Claude; de Jong, Marion; Schulz, Stefan; Maecke, Helmut R (2006). Design, synthesis, and biological evaluation of somatostatin-based radiopeptides. Chemistry & biology, 13(10), pp. 1081-90. San Francisco, Calif.: Current Biology Ltd. 10.1016/j.chembiol.2006.08.012

Lebtahi, Rachida; Moreau, Severine; Marchand-Adam, Sylvain; Debray, Marie-Pierre; Brauner, Michel; Soler, Paul; Marchal, Joëlle; Raguin, Olivier; Gruaz-Guyon, Anne; Reubi, Jean-Claude; Le Guludec, Dominique; Crestani, Bruno (2006). Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis. Journal of nuclear medicine, 47(8), pp. 1281-7. New York, N.Y.: Society of Nuclear Medicine

Nock, Berthold A; Nikolopoulou, Anastasia; Reubi, Jean-Claude; Maes, Veronique; Conrath, Peter; Tourwé, Dirk; Maina, Theodosia (2006). Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTc. Journal of medicinal chemistry, 49(15), pp. 4767-76. Easton, Pa.: American Chemical Society 10.1021/jm060415g

Grace, Christy Rani R; Erchegyi, Judit; Koerber, Steven C; Reubi, Jean Claude; Rivier, Jean; Riek, Roland (2006). Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR. Journal of medicinal chemistry, 49(15), pp. 4487-96. Easton, Pa.: American Chemical Society 10.1021/jm060363v

Lantry, Laura E; Cappelletti, Enrico; Maddalena, Mary Ellen; Fox, Jaclyn S; Feng, Weiwei; Chen, Jianqing; Thomas, Regi; Eaton, Stephen M; Bogdan, Nancy J; Arunachalam, Thangavel; Reubi, Jean Claude; Raju, Natarajan; Metcalfe, Edmund C; Lattuada, Luciano; Linder, Karen E; Swenson, Rolf E; Tweedle, Michael F; Nunn, Adrian D (2006). 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. Journal of nuclear medicine, 47(7), pp. 1144-52. New York, N.Y.: Society of Nuclear Medicine

Kneifel, Stefan; Cordier, Dominik; Good, Stephan; Ionescu, Mihai C S; Ghaffari, Anthony; Hofer, Silvia; Kretzschmar, Martin; Tolnay, Markus; Apostolidis, Christos; Waser, Beatrice; Arnold, Marlene; Mueller-Brand, Jan; Maecke, Helmut R; Reubi, Jean Claude; Merlo, Adrian (2006). Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance p. Clinical cancer research, 12(12), pp. 3843-50. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-05-2820

Ji, G C; Zhou, S T; Shapiro, G; Reubi, J C; Jurczyk, Simona; Carlton, S M (2006). Analgesic activity of a non-peptide imidazolidinedione somatostatin agonist: in vitro and in vivo studies in rat. Pain, 124(1-2), pp. 34-49. Amsterdam: Elsevier 10.1016/j.pain.2006.03.014

Maina, Theodosia; Nock, Berthold A; Cordopatis, Paul; Bernard, Bert F; Breeman, Wout A P; van Gameren, Arthur; van den Berg, Ria; Reubi, Jean-Claude; Krenning, Eric P; de Jong, Marion (2006). [(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate. European journal of nuclear medicine and molecular imaging, 33(7), pp. 831-40. Berlin: Springer 10.1007/s00259-006-0068-8

Gairí, Margarida; Saiz, Pilar; Madurga, Sergio; Roig, Xavier; Erchegyi, Judit; Koerber, Steven C; Reubi, Jean Claude; Rivier, Jean E; Giralt, Ernest (2006). Conformational analysis of a potent SSTR3-selective somatostatin analogue by NMR in water solution. Journal of Peptide Science, 12(2), pp. 82-91. Chichester: John Wiley & Sons 10.1002/psc.743

Reubi, JC (2006). Radiopeptide targeting for tumor therapy: peptide receptor distribution. In: , (ed.) Radionuclide peptide cancer therapy Chinol M (pp. 31-39). London: Taylor & Francis

Rivier, J; Gulyas, J; Erchegyi, J; Koerber, SC; Grace, C; Riek, R; DiGruccio, M; Perrin, M; Rivier, C; Eltschinger, V; Waser, B; Cescato, R; Reubi, JC; Vale, W (2006). Guiding principles applied in the design of GPCR-selective hypothalamic hormone agonists and antagonists. In: (pp. 117-138). Heidelberg: Springer Verlag 10.1007/3-540-34447-0_8

Gugger, M; Reubi, JC (2006). Somatostatin. In: , (ed.) (pp. 1123-1130). Amsterdam: Elsevier

Koerner, M; Reubi, JC (2006). Somatostatin and NPY. In: , (ed.) (pp. 435-444). Amsterdam: Elsevier

Provide Feedback